US Patent Issued to Sanofi on March 31 for "Combination therapies against cancer targeting CD38 and TGF-Beta" (Belgian, American Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,167, issued on March 31, was assigned to Sanofi (Paris).

"Combination therapies against cancer targeting CD38 and TGF-Beta" was invented by Francisco Adrian (Belmont, Mass.), Richard C. Gregory (Framingham, Mass.), Gary Shapiro (Arlington, Mass.) and Helgi Van De Velde (Retie, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to combination cancer therapies targeting CD38 and TGF-Beta using antibodies specific for these targets. Also provided are compositions useful in the therapies."

The patent was filed on July 10, 2019, under Application No. 17/259,135.

*For further information, including images, charts and ...